top of page
Concept illustration
MitraMag:
Next-generation
bioresorbable
implant
against
infective
endocarditis
A bioresorbable cardiac implant under development to inhibit bacterial adhesion, reduce infection recurrence, and eliminate long-term foreign body risk
MitraMag, a bioresorbable annuloplastic implant:
A dual-component antimicrobial treatment technology
Bioresorbable Core Structure
ZX00 (magnesium alloy).
Ensures mechanical strengthening of the heart valve annulus while providing full bioresorption ability
Matrix-Shell For Agent Control
Electrospun polycaprolactone (PCL).
A structural shell for the precise embedding and regulation of the active substance
Local Antimicrobial Agent
0.5 wt% silver nanoparticles (AgNPs).
Silver nanoparticles embedded in the PCL matrix release Ag ions and thus form an efficient barrier against biofilm formation.
Concept illustration
News updates
The founder’s team #Bruno Podesser, #Helga Bergmeister, #Wolfgang Tuechler, #Manfred Bammer of CardEvo is very proud to share that our start-up, a spin-off of the Medizinische Universität Wien, has been chosen as one of the Falling Walls Venture TOP 100 Science Start-ups to Watch in 2026 by Falling Walls Foundation!
🚀 This recognition highlights our work in developing a bioresorbable annuloplasty ring for mitral valve repair, while delivering local antibacterial therapy in order to break the wall of infective endocarditis in heart valves.
bottom of page